No Deviation, specialized in commissioning, qualification & validation (CQV) and digital validation, has joined Efor Group, a global life sciences consultancy focused on quality and compliance for the pharmaceutical, biotechnology, and medical device industries, employing more than 3,000 professionals in 18 countries worldwide.
This integration strengthens No deviation’s ability to support pharmaceutical and biotechnology manufacturers operating across increasingly complex, fast-paced and highly regulated environments.
For clients, the integration means end-to-end product expertise, expanded global delivery capabilities, and strengthened multisite support.
Supporting Global Projects with Local Execution
Life sciences companies are facing growing pressure to accelerate project delivery and reduce costs while maintaining compliance across multiple regions and manufacturing sites. In this context, validation activities are becoming increasingly digital, data-driven and globally interconnected.
With teams across Singapore, China and Ireland, No deviation has developed strong expertise in supporting CQV and digital validation programs in Asia-Pacific and beyond. Through its integration into Efor Group, these capabilities are now reinforced by a broader international network across Europe, North America, the Middle East and Asia.
For manufacturers managing global CAPEX projects, technology transfers or parallel facility expansions, this translates into:
- Harmonized CQV and validation approaches across regions
- Improved coordination between global governance and local execution
- Extended access to multidisciplinary quality and compliance expertise
- Enhanced resource flexibility and project scalability
- Round-the-clock collaboration across international teams
Advancing Digital Validation
As a Kneat Gold Partner, No deviation has been actively supporting pharmaceutical companies in transitioning from paper-based validation to digital validation workflows.
By implementing paperless validation strategies, clients can reduce review cycles, improve traceability, strengthen data integrity and maintain audit readiness from day one. These approaches also support compliance with regulatory expectations including Annex 11 and 21 CFR Part 11.
The integration with Efor further strengthens these capabilities by combining digital validation expertise with broader lifecycle consulting services, helping manufacturers modernize validation practices while maintaining operational and regulatory control.
A Shared Focus on Quality and Compliance
The integration reflects a shared commitment between No deviation and Efor to support life sciences manufacturers through increasingly complex regulatory and operational challenges.
By combining global reach with execution excellence, Efor aims to help clients deliver projects more efficiently, harmonize quality standards across sites and accelerate time-to-market without compromising compliance.
About Efor Group
Efor Group is now a leading international player specializing in quality and regulatory compliance for the healthcare industries. With more than 3,000 employees across 18 countries, the Group supports global leaders in the pharmaceutical, biotechnology, and medical device sectors in ensuring the compliance of their manufacturing sites and accelerating the delivery of innovative therapeutic solutions to patients.
Its mission is to remove technical and regulatory barriers so that innovation can reach patients faster, under the highest standards of safety and reliability.
Committed to becoming a global leader while remaining true to its founding values, Efor Group fully integrates social and environmental priorities into its operations. Through concrete initiatives that support society, sustainability, and innovation, the Group pursues a long-term growth vision guided by excellence, commitment, and collaboration.
For further information, please contact: contact@efor-group.com
